Neurocrine Biosciences In...

NASDAQ: NBIX · Real-Time Price · USD
132.85
1.54 (1.17%)
At close: Aug 15, 2025, 3:59 PM
132.90
0.04%
After-hours: Aug 15, 2025, 04:34 PM EDT

Neurocrine Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
341.3M 249.7M 154.5M 89.6M
Depreciation & Amortization
27.1M 21.3M 15.6M 10.9M
Stock-Based Compensation
195.5M 194.3M 173.1M 134.2M
Other Working Capital
n/a 47.8M -17.2M -9.2M
Other Non-Cash Items
154.6M -46.9M 44.5M 800K
Deferred Income Tax
-123.1M -56.7M 19.1M 4.3M
Change in Working Capital
n/a 28.2M -67.4M 16.7M
Operating Cash Flow
595.4M 389.9M 339.4M 256.5M
Capital Expenditures
-38.2M -28.3M -16.5M -23.4M
Cash Acquisitions
n/a n/a -42.7M 4.6M
Purchase of Investments
-1.06B -1.41B -628.9M -804.7M
Sales Maturities Of Investments
967.5M 972.4M 511M 697.9M
Other Investing Acitivies
n/a n/a -117.9M -4.6M
Investing Cash Flow
-126.8M -467.1M -177.1M -130.2M
Debt Repayment
-308.8M n/a -279M -100K
Common Stock Repurchased
-300M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
122.1M 65.3M n/a 27.5M
Financial Cash Flow
-486.7M 65.3M -234.3M 27.4M
Net Cash Flow
-18.1M -11.6M -73.3M 153.7M
Free Cash Flow
557.2M 361.6M 322.9M 233.1M